15921 Absolute PASI response up to 52 weeks with brodalumab in patients with moderate to severe plaque psoriasis
Year: 2020
Type: article
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3108845816
